Info@ThinkPinkRocks.com

Positive results from PROLOR Biotech’s hGH-CTP Phase II trial for growth hormone deficiency

PROLOR Biotech, Inc. today reported top-line results from a Phase II four-month treatment extension study of hGH-CTP, its long-acting version of human growth hormone, in growth hormone deficient adults.

View article:
Positive results from PROLOR Biotech’s hGH-CTP Phase II trial for growth hormone deficiency

Share

Leave a Reply

Solve : *
25 + 12 =